Prelude Therapeutics, Inc. (PRLD)

2.78 +0.51 (+22.47%) USD  |  NASDAQ  |  Feb 20, 16:00
2.78 0.00 (0.00%) After-Hours: 20:00
More

Prelude Therapeutics Long Term Deferred Tax Assets (Quarterly)

Long Term Deferred Tax Assets (Quarterly) Chart

View Long Term Deferred Tax Assets (Quarterly) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Assets (Quarterly) Benchmarks

View Long Term Deferred Tax Assets (Quarterly) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. --
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. --
Relay Therapeutics, Inc. --